Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (261-270 of 391) with videos related to

Pageof 40
Sort By:
Journal of Alzheimer'S Disease : JAD|December 28, 2020
Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite AlterationsPratishtha Chatterjee, Anne M Fagan, Chengjie Xiong, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker TestsNoëlle Warmenhoven, Gemma Salvadó, Shorena Janelidze, et al.
Research Square|March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's DiseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2024
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloidMatthew R Meyer, Kristopher M Kirmess, Stephanie Eastwood, et al.
Nature Medicine|July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2022
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brainsBrenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, et al.
Brain : a Journal of Neurology|October 29, 2024
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker testsNoëlle Warmenhoven, Gemma Salvadó, Shorena Janelidze, et al.
Brain : a Journal of Neurology|September 22, 2018
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's diseaseMiguel Ángel Araque Caballero, Marc Suárez-Calvet, Marco Duering, et al.
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Pageof 40

Showing results (261-270 of 391) with videos related to

Sort By:
Pageof 40
Journal of Alzheimer'S Disease : JAD|December 28, 2020
Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite AlterationsPratishtha Chatterjee, Anne M Fagan, Chengjie Xiong, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker TestsNoëlle Warmenhoven, Gemma Salvadó, Shorena Janelidze, et al.
Research Square|March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's DiseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2024
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloidMatthew R Meyer, Kristopher M Kirmess, Stephanie Eastwood, et al.
Nature Medicine|July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2022
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brainsBrenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, et al.
Brain : a Journal of Neurology|October 29, 2024
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker testsNoëlle Warmenhoven, Gemma Salvadó, Shorena Janelidze, et al.
Brain : a Journal of Neurology|September 22, 2018
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's diseaseMiguel Ángel Araque Caballero, Marc Suárez-Calvet, Marco Duering, et al.
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Pageof 40